Emerald Clinical
Glenn Kerkhof is the Interim Chief Executive Officer of Emerald Clinical and, before that, was Executive Chairman of George Clinical. Glenn has over 30 years’ experience in the pharmaceutical services industry and joined George Clinical from Chiltern, where he was Chief Executive Officer, based in London. Before Chiltern, Glenn served as Vice President, Clinical Services for Charles River Laboratories, and as Vice President, Clinical Europe for Inveresk Research. He is a Non-Executive Director of Infensa Biosciences, and his previous directorships include Cell Care Pty. Ltd. Glenn, based in Melbourne, works closely with the executive team to formulate and execute Emerald Clinical’s global strategy.
This person is not in any teams
This person is not in any offices
Emerald Clinical
Emerald Clinical is a leading global clinical research organization founded in Asia-Pacific driven by scientific expertise and operational excellence. With over 20 years of experience and more than 500 people managing 40 geographical locations throughout the Asia-Pacific region, USA and Europe, Emerald Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials. Stay up to date on the latest clinical research news, case studies and perspectives from Emerald Clinical thought leaders by signing up for our monthly e-newsletter. emeraldclinical.com/subscribe/newsletter